Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma

Events
Written by Stine Krag Brunvold

In April 2024, Cure SMA hosted a clinical trial update webinar with NMD Pharma.

Check it out here:


Stine Krag Brunvold
Previous

NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
Next

NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US